🔎 Trials Near Me

Home › Multiple Myeloma › Iowa › Des Moines

Multiple Myeloma clinical trials in Des Moines, IA

5 studies for Multiple Myeloma are looking for participants at sites in and around Des Moines (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

RecruitingPhase 3
  • Mission Cancer Blood University of Iowa Health Care, Waukee · 14 mi away
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07518186

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

RecruitingPhase 3
  • Mission Cancer Blood, Waukee · 14 mi away
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07258511

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

RecruitingPhase 3
  • Iowa Methodist Medical Center, Des Moines
  • UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines
  • Broadlawns Medical Center, Des Moines
  • and 9 more
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT04566328

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

RecruitingPhase 3
  • Mercy Medical Center - Des Moines, Des Moines
  • Mission Cancer and Blood - Laurel, Des Moines
  • Mercy Medical Center-West Lakes, West Des Moines · 6 mi away
  • and 3 more
All ages · All sexes · Updated Jun 10, 2026 · NCT05561387

About Multiple Myeloma

Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. Discover symptoms, diagnostic tests, and treatments for myeloma.

More about Multiple Myeloma on MedlinePlus

Multiple Myeloma trials in other cities

Other studies in Des Moines

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.